EU Approves Sanofi's Menquadfi To Treat Infants Against Invasive Meningococcal Disease
SNY•EU approves Menquadfi for infants
- Sanofi’s Menquadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease.
SNY•SNY•
